Tremfya gets positive opinion from (CHMP) for psoriatic arthritis

[Fred]

Tremfya (guselkumab) gets a positive recommendation for psoriatic arthritis in the EU.

Quote:

---

Janssen announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending the expanded use of TREMFYA (guselkumab) for the treatment of adult patients with active psoriatic arthritis (PsA) in the European Union (EU). Guselkumab is currently approved in the EU for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy.

Source: janssen.com

Tremfya (guselkumab)

[KatT]

     my next treatment!!!

[jiml]

Great its been approved for psoriatic arthritis in Europe as it's another tool to help sufferers

[Fred]

Update: Approval has now gone through for the treatment of adult patients with active psoriatic arthritis (PsA) who have had an inadequate response or who have been intolerant to a prior disease-modifying antirheumatic drug (DMARD) therapy.